SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 77 filers reported holding SAVARA INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,525,416 | -21.8% | 3,313,602 | -33.5% | 47.59% | +2.9% |
| Q2 2023 | $16,026,005 | +19.2% | 4,980,804 | -27.8% | 46.25% | +36.1% |
| Q1 2023 | $13,448,274 | +25.8% | 6,896,551 | 0.0% | 33.97% | +24.4% |
| Q4 2022 | $10,689,654 | -0.0% | 6,896,551 | 0.0% | 27.30% | +35.8% |
| Q3 2022 | $10,690,000 | +2.0% | 6,896,551 | 0.0% | 20.10% | +42.7% |
| Q2 2022 | $10,483,000 | +16.0% | 6,896,551 | 0.0% | 14.08% | +25.4% |
| Q1 2022 | $9,034,000 | +5.3% | 6,896,551 | -0.3% | 11.23% | +60.2% |
| Q4 2021 | $8,577,000 | -9.9% | 6,916,551 | +0.3% | 7.01% | -9.1% |
| Q3 2021 | $9,517,000 | -5.9% | 6,896,551 | +15.9% | 7.71% | +11.3% |
| Q2 2021 | $10,117,000 | -15.4% | 5,951,015 | +3.5% | 6.93% | -10.8% |
| Q1 2021 | $11,965,000 | – | 5,752,215 | – | 7.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |